Purpose: Previous studies have pointed to the importance of subchondral bone restoration in the repair of cartilage defects. In osteochondral defects, it may be necessary to restore the underlying bone to facilitate the successful repair of cartilage. Biodegradable scaffolds and demineralized cortical bone have been investigated for the repair of focal defects. However, those materials have had varying levels of success. This study investigates the use of a novel allograft sponge of demineralized cancellous bone to fill and repair osteochondral defects in a goat model. It was hypothesized that the unique properties of this sponge would facilitate restoration of the subchondral bone with subsequent fill of the cartilage defect, and support integration with the surrounding tissues. Methods: Osteochondral defects (4.5mm Ø, 8mm depth) were created in the trochlear groove of goats. Two defects were created; one defect filled with acellular allograft sponge (Bacterin) and the other filled with an autograft core. The sponge is a demineralized goat cancellous bone plug created similarly to commerciallyavailable human allograft products (OsteoSponge™. The knee was splinted for 2 weeks. After 12 months, the animals were sacrificed and the defects underwent macroscopic scoring, MRI morphological analysis, microCT scanning, and histological scoring. Data were analyzed using one-way ANOVA with data shown as average ± SD with 4 replicates. Results: All defects were filled with white and glistening repair tissue at 12 months and the defects scored similarly in gross appearance. Defects were generally filled with tissue that was flush to the native cartilage based on histological and MRI analysis. Restoration of bone was similar for the sponge and autograft groups and all samples demonstrated complete osseous incorporation on MRI. Tidemark restoration was partial or complete for most of the sponge samples. Histological and MRI analysis demonstrated cartilage repair tissue that resembled hyaline cartilage, with histological scores being similar between the groups for matrix staining, cell morphology, defect architecture, and surface architecture. Histological scores for integration were significantly higher for the sponge-treated defects when compared to the controls (p<0.001, Fig. 1 ).
Conclusions:
The novel DBM sponge used in this study was shown to support subchondral bone restoration in focal osteochondral defects and resulted in defect fill similar to that observed for the autograft controls. The sponge's unique properties facilitated a high-degree of press-fit while conforming to the contour of the defect. The results achieved with the sponge were statistically similar to those of the autograft controls in all histological scoring categories with the exception of integration, where the sponge was significantly better than the controls. Overall, this study demonstrates the use of a novel sponge to successfully fill osteochondral defects, resulting in repair of the defects with tissue similar in quality to that of autograft-filled defects and improved integration with the surrounding cartilage. Further experimentation is needed to confirm outcome at later timepoints and in larger defects. The safety and efficacy of the allograft sponge has not been validated in human joints. Purpose: Cartilage repair still remains a challenge to the main investigators in the field. Cellular therapy is long far away from the desired regeneration of cartilage for cartilage damage. Our goal is to get MSC from umbilical cord stroma cells and differentiate them to obtain chondrocyte-like cells which could be able transplanted in injured joint to regenerate the tissue. Recent studies from our lab demonstrate that a new model of chondrogenesis in vitro is possible using conditioned medium through the spheroid formation. Methods: The umbilical cord tissues were obtained from caesareans from normal women in the Maternity Facility at Complejo Hospitalario Universitario A Coruña under the supervision of the hospital ethic committee. MSC were isolated and growth from umbilical cord stroma tissue using an enzymatic digestion and cultured adhered to the plastic plate. After two passages the cells were characterized by flow cytometry and immunofluorescent analysis. Adypogenesis, osteogenesis and chondrogenesis was induced to test the mesodermic potential of this population. Chondrogenic process was performed using our model which consisted in growing the cells during two days in medium with FCS 15%. After 2 days the medium was replaced by a medium with KO serum and TGF-β3. Spheroids were formed by two days in culture and this three-dimensional structure help to produce the characteristic protein which form part of the extra-cellular matrix of cartilage. The spheroids were frozen in OCT at 4, 7, 14, 28 and 46 days in defined medium culture for a posterior protein and genetic expression by immunohistochemistry and RT-PCR analysis. Results: The cells were positive for undifferentiated markers like OCT4, STRO1 and Nanog and for MSC markers like CD90 (90%), CD44 (25%), CD69 (12%) and CD106 (12%), whereas they were negative for haematopoietic markers like CD34 and CD45 (less than 4% and 5% respectively). Using a commercial medium to induce adipogenesis and osteogenesis, we obtained 100% differ-
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CHONDROCYTE-LIKE CELLS DIFFERENTATED FROM HUMAN UMBILICAL CORD STROMA MESENCHYMAL STEM CELLS
